Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Yijing Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 32
Average round size
info
The average size of a deal this fund participated in
$88M
Portfolio companies 29
Rounds per year 3.56
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Information Technology
  • Hardware
  • Pharmaceutical
Summary

Yijing Capital is the famous VC, which was founded in 2015. The company was established in Asia in China. The leading representative office of defined VC is situated in the Shanghai.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are Software, Consulting. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Shanutec, iyiou.com, Yidebang. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Yijing Capital, startups are often financed by Qiaojing Capital, Gaorong Capital, Xiamen Changrong Investment Management. The meaningful sponsors for the fund in investment in the same round are Xiamen Changrong Investment Management, StarVC, Sinovation Ventures. In the next rounds fund is usually obtained by Xiamen Changrong Investment Management, StarVC.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Yijing Capital:
Typical Co-investors
Yijing Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Yijing Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BDT Capital Partners Chicago, Illinois, United States
Century Securities China, Guangdong, Shenzhen
Chingona Ventures Chicago, Illinois, United States
EOS Global China, Hong Kong, Hong Kong Island
Front Street Capital Canada, Ontario, Toronto
Gate.io Illinois, Malta, United States
Jieliyuan Group -
Newport Private Wealth Canada, Ontario, Toronto
Prime Holdings -
Rio Ventures -
SkyKnight Capital California, San Francisco, United States
Stock Exchange Executive Council of China Beijing, Beijing, China
Sypress -
Technologies Investment New York, New York, United States
The J&J Group -
The Pink Ceiling North Carolina, Raleigh, United States
Vision Blue Solutions County Dublin, Dublin, Ireland
Yaskawa Electric China, Huangpu, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Phomera

Manufacturing
$15M29 Apr 2024 Zhuhai, Guangdong, China

Arnatar Therapeutics

$50M08 Apr 2024 San Diego, California, United States

Kangpu Bio-Pharma

Biopharma
Clinical Trials
Health Care
$15M30 Aug 2023 Shanghai, China

Taichu Biotechnology

Medical
Pharmaceutical
Product Research
08 May 2023 Shanghai, Shanghai, China

Tasogare

Coffee
Consumer
01 Aug 2022 Hangzhou, Zhejiang, China

Zhongguancun Shuimu Medical

Hardware
Medical
Medical Device
$15M22 Jul 2022 Beijing, Beijing, China

CytoNiche

Biotechnology
Health Care
$46M03 Mar 2022 Dongcheng District, Beijing, China

InnoStar Semiconductor

Electronics
Semiconductor
04 Jan 2022 Shanghai, China

Bivision

Biopharma
Health Diagnostics
01 Jan 2022 Shanghai, Shanghai, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Yijing Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 32
Average round size 88M
Rounds per year 3.56
Peak activity year 2021
Lead investments 6
Follow on index 0.09
Group Appearance index 0.84

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Phomera

Manufacturing
$15M29 Apr 2024 Zhuhai, Guangdong, China

Arnatar Therapeutics

$50M08 Apr 2024 San Diego, California, United States

Kangpu Bio-Pharma

Biopharma
Clinical Trials
Health Care
$15M30 Aug 2023 Shanghai, China

Taichu Biotechnology

Medical
Pharmaceutical
Product Research
08 May 2023 Shanghai, Shanghai, China

Tasogare

Coffee
Consumer
01 Aug 2022 Hangzhou, Zhejiang, China

Zhongguancun Shuimu Medical

Hardware
Medical
Medical Device
$15M22 Jul 2022 Beijing, Beijing, China

CytoNiche

Biotechnology
Health Care
$46M03 Mar 2022 Dongcheng District, Beijing, China

InnoStar Semiconductor

Electronics
Semiconductor
04 Jan 2022 Shanghai, China

Bivision

Biopharma
Health Diagnostics
01 Jan 2022 Shanghai, Shanghai, China
Crunchbase icon

Content report

The following text will be sent to our editors: